Literature DB >> 74095

The chemotherapy of head and neck cancer.

S K Carter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 74095

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  Phase II trial of carboplatin and vinblastine in advanced squamous-cell carcinoma of the head and neck.

Authors:  S El-Sayed; R P Symonds; A G Robertson; J Paul; J McGarva
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Current role of chemotherapy in head and neck cancer.

Authors:  J S Tobias
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

3.  Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.

Authors:  P Espana; F Smith; J Abrams; D Haidak; W Ueno; P Woolley; P Schein
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  [Chemotherapy with cisplatin-bleomycin and subsequent radiotherapy in advanced head and neck tumors].

Authors:  A Schmieder; H Jacobs; H Maurer; H Pfeifer
Journal:  Klin Wochenschr       Date:  1984-01-02

5.  Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.

Authors:  A Thyss; M Schneider; J Santini; C Caldani; J Vallicioni; P Chauvel; F Demard
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

6.  Response to R-CHOP in HPV-related squamous cell carcinoma of base of tongue: a case report.

Authors:  Ting Martin Ma; Hyunseok Kang; Steven P Rowe; Ana P Kiess
Journal:  Cancers Head Neck       Date:  2018-05-24

7.  Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate.

Authors:  B J Braakhuis; E J Schoevers; E C Heinerman; G Sneeuwloper; G B Snow
Journal:  Br J Cancer       Date:  1983-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.